Evidence map›Paper›PMID 36322465›Full record

ArticleThe British journal of surgery2022

Benchmarking of robotic and laparoscopic spleen-preserving distal pancreatectomy by using two different methods.

Tess M E van Ramshorst, Alessandro Giani, Michele Mazzola, Safi Dokmak, Fadhel Samir Ftériche, Alessandro Esposito, Matteo de Pastena, Sanne Lof, Bjørn Edwin, Mushegh Sahakyan and 27 more

Abstract read
In one paragraph

Article in The British journal of surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Defining what is left in a left-sided pancreatectomy.The British journal of surgery · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Tess M E van RamshorstDepartment of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.
Alessandro GianiDivision of Minimally Invasive Surgical Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.ORCID 0000-0003-0718-2321
Michele MazzolaDivision of Minimally Invasive Surgical Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.ORCID 0000-0002-3546-197X
Safi DokmakDepartment of Hepatopancreatobiliary Surgery and Liver Transplantation, Beaujon Hospital, Clichy, France.ORCID 0000-0002-7811-2155
Fadhel Samir FtéricheDepartment of Hepatopancreatobiliary Surgery and Liver Transplantation, Beaujon Hospital, Clichy, France.
Alessandro EspositoDepartment of Surgery, Pancreas Institute, Verona University Hospital, Verona, Italy.
Matteo de PastenaDepartment of Surgery, Pancreas Institute, Verona University Hospital, Verona, Italy.ORCID 0000-0001-5244-4357
Sanne LofAmsterdamum UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.ORCID 0000-0002-5688-8761
Bjørn EdwinIntervention Centre and Department of Hepatopancreatobiliary Surgery, Oslo University Hospital, also Institute of Medicine, University of Oslo, Oslo, Norway.
Mushegh SahakyanIntervention Centre, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-4815-7694
Ugo BoggiDepartment of Surgery, University Hospital of Pisa, Pisa, Italy.ORCID 0000-0002-7505-5896
Emanuele Federico KauffmanDepartment of Surgery, University Hospital of Pisa, Pisa, Italy.
Jean Michel FabreDepartment of Surgery, Saint-Éloi Hospital, Montpellier, France.
Regis Francois SoucheDepartment of Surgery, Saint-Éloi Hospital, Montpellier, France.
Alessandro ZerbiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy, and IRCCS Humanitas Research Hospital, Rozzano, Italy.
Giovanni ButturiniDepartment of Hepatopancreatobiliary Surgery, Pederzoli Hospital, Peschiera del Garda, Italy.
Quintus MolenaarDepartment of Surgery, Regional Academic Cancer Centre Utrecht, UMC Utrecht Cancer Centre and St Antonius Hospital Nieuwegein, University Medical Centre Utrecht, Utrecht, the Netherlands.
Bilal Al-SarirehDepartment of Surgery, Morriston Hospital, Swansea, UK.
Marco V MarinoGeneral and Emergency Surgery Department, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.ORCID 0000-0002-0466-4467
Tobias KeckDepartment of Surgery, University Medical Centre Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Steven A WhiteDepartment of Surgery, Freeman Hospital, Newcastle upon Tyne, Newcastle, UK.
Riccardo CasadeiDepartment of Surgery, Sant'Orsola Malphigi Hospital, Bologna, Italy.
Fernando BurdioDepartment of Surgery, University Hospital del Mar, Barcelona, Spain.
Bergthor BjörnssonDepartment of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0001-9704-1260
Zahir SoonawallaDepartment of Surgery, Oxford University Hospital, Oxford, UK.
Bas Groot KoerkampDepartment of Surgery, Erasmus Medical Centre, Rotterdam, theNetherlands.ORCID 0000-0003-1917-6973
Giuseppe Kito FusaiHepatopancreatobiliary and Liver Transplant Unit, Royal Free London, London, UK.
Patrick PessauxDivision of Hepato-Biliary and Pancreatic Surgery, Nouvel Hôpital Civil, University Hospital, Institut Hospitalo-Universitaire de Strasbourg, Strasbourg, France.
Asif JahDepartment of Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Andrea PietrabissaDepartment of Surgery, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Thilo HackertDepartment of Surgery, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-7012-1196
Mathieu D'HondtDepartment of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.
Elizabeth PandoDepartment of Surgery, Vall d'Hebron University Hospital, Barcelona, Spain.
Marc G BesselinkAmsterdamum UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.ORCID 0000-0003-2650-9350
Giovanni FerrariDivision of Minimally Invasive Surgical Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Mohammad Abu HilalDepartment of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.
European Consortium on Minimally Invasive Pancreatic Surgery

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBenchmarking is an important tool for quality comparison and improvement. However, no benchmark values are available for minimally invasive spleen-preserving distal pancreatectomy, either laparoscopically or robotically assisted. The aim of this study was to establish benchmarks for these techniques using two different methods.

methodsData from patients undergoing laparoscopically or robotically assisted spleen-preserving distal pancreatectomy were extracted from a multicentre database (2006-2019). Benchmarks for 10 outcomes were calculated using the Achievable Benchmark of Care (ABC) and best-patient-in-best-centre methods.

resultsOverall, 951 laparoscopically assisted (77.3 per cent) and 279 robotically assisted (22.7 per cent) procedures were included. Using the ABC method, the benchmarks for laparoscopically assisted and robotically assisted spleen-preserving distal pancreatectomy respectively were: 150 and 207 min for duration of operation, 55 and 100 ml for blood loss, 3.5 and 1.7 per cent for conversion, 0 and 1.7 per cent for failure to preserve the spleen, 27.3 and 34.0 per cent for overall morbidity, 5.1 and 3.3 per cent for major morbidity, 3.6 and 7.1 per cent for pancreatic fistula grade B/C, 5 and 6 days for duration of hospital stay, 2.9 and 5.4 per cent for readmissions, and 0 and 0 per cent for 90-day mortality. Best-patient-in-best-centre methodology revealed milder benchmark cut-offs for laparoscopically and robotically assisted procedures, with operating times of 254 and 262.5 min, blood loss of 150 and 195 ml, conversion rates of 5.8 and 8.2 per cent, rates of failure to salvage spleen of 29.9 and 27.3 per cent, overall morbidity rates of 62.7 and 55.7 per cent, major morbidity rates of 20.4 and 14 per cent, POPF B/C rates of 23.8 and 24.2 per cent, duration of hospital stay of 8 and 8 days, readmission rates of 20 and 15.1 per cent, and 90-day mortality rates of 0 and 0 per cent respectively.

conclusionTwo benchmark methods for minimally invasive distal pancreatectomy produced different values, and should be interpreted and applied differently.

Indexed as

LaparoscopyPancreatic NeoplasmsRobotic Surgical ProceduresBenchmarkingHumansOperative TimePancreatectomyRetrospective StudiesSpleenTreatment Outcome

Identifiers

PMID36322465
PMCPMC10364499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.